Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations

Hematol Oncol. 2019 Aug;37(3):319-322. doi: 10.1002/hon.2603. Epub 2019 Mar 28.

¹ Department of Hematology and Medical Oncology, University Medicine Göttingen (UMG), Göttingen, Germany.
² Department of Hematology and Oncology, Medical Faculty Mannheim of the Heidelberg University, Mannheim, Germany.
³ University Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Bern, Switzerland.
⁴ Center of Laboratory Medicine (ZLM)/University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, Bern, Switzerland.
⁵ Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland.

No abstract available

Publication types